DK1196403T3 - Antipsykotiske N-aralkylaminer - Google Patents

Antipsykotiske N-aralkylaminer

Info

Publication number
DK1196403T3
DK1196403T3 DK00946022T DK00946022T DK1196403T3 DK 1196403 T3 DK1196403 T3 DK 1196403T3 DK 00946022 T DK00946022 T DK 00946022T DK 00946022 T DK00946022 T DK 00946022T DK 1196403 T3 DK1196403 T3 DK 1196403T3
Authority
DK
Denmark
Prior art keywords
aralkylamines
antipsychotic
Prior art date
Application number
DK00946022T
Other languages
Danish (da)
English (en)
Inventor
Robert Boigegrain
Pierre Lair
Martine Bourrie
Raymond Paul
Martine Poncelet
Jean-Claude Vernieres
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1196403T3 publication Critical patent/DK1196403T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00946022T 1999-07-02 2000-06-27 Antipsykotiske N-aralkylaminer DK1196403T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908532A FR2795724B1 (fr) 1999-07-02 1999-07-02 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DK1196403T3 true DK1196403T3 (da) 2006-03-20

Family

ID=9547628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00946022T DK1196403T3 (da) 1999-07-02 2000-06-27 Antipsykotiske N-aralkylaminer

Country Status (31)

Country Link
US (1) US6908914B1 (enExample)
EP (1) EP1196403B1 (enExample)
JP (1) JP4931309B2 (enExample)
KR (1) KR100760446B1 (enExample)
CN (1) CN1156462C (enExample)
AR (1) AR029374A1 (enExample)
AT (1) ATE309231T1 (enExample)
AU (1) AU778299B2 (enExample)
BG (1) BG65209B1 (enExample)
BR (1) BR0012463B1 (enExample)
CA (1) CA2376691C (enExample)
CO (1) CO5021196A1 (enExample)
CZ (1) CZ300936B6 (enExample)
DE (1) DE60023898T2 (enExample)
DK (1) DK1196403T3 (enExample)
EA (1) EA004048B1 (enExample)
ES (1) ES2250160T3 (enExample)
FR (1) FR2795724B1 (enExample)
HK (1) HK1043122A1 (enExample)
HR (1) HRP20010949B1 (enExample)
HU (1) HU228983B1 (enExample)
IL (2) IL147069A0 (enExample)
ME (1) MEP25508A (enExample)
MX (1) MXPA01013207A (enExample)
NO (1) NO322230B1 (enExample)
NZ (1) NZ516342A (enExample)
RS (1) RS50266B (enExample)
TW (1) TWI285640B (enExample)
UA (1) UA71009C2 (enExample)
WO (1) WO2001002380A1 (enExample)
ZA (1) ZA200200018B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE327673T1 (de) * 2001-08-23 2006-06-15 Bayer Cropscience Sa Substituierte propargylamine
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790971A (fr) * 1971-11-09 1973-05-07 Janssen Pharmaceutica Nv Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen
JPS504086A (enExample) * 1973-01-18 1975-01-16
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines
EP0347123A3 (en) * 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine
FR2663328B1 (fr) * 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1993000313A2 (en) * 1991-06-27 1993-01-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
FR2751645B1 (fr) 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
TR199902283T2 (xx) * 1997-03-18 1999-12-21 Smithkline Beecham P.L.C. �kame edilmi� izokuinolin t�revleri ve bunlar�n antikonvulsant olarak kullan�m�.

Also Published As

Publication number Publication date
NO20016392D0 (no) 2001-12-27
US6908914B1 (en) 2005-06-21
BR0012463A (pt) 2002-04-02
MEP25508A (en) 2010-06-10
ATE309231T1 (de) 2005-11-15
CN1367783A (zh) 2002-09-04
CZ300936B6 (cs) 2009-09-16
ES2250160T3 (es) 2006-04-16
NZ516342A (en) 2003-08-29
EA200101209A1 (ru) 2002-06-27
ZA200200018B (en) 2003-01-02
HUP0202200A3 (en) 2002-12-28
RS50266B (sr) 2009-07-15
DE60023898D1 (de) 2005-12-15
FR2795724A1 (fr) 2001-01-05
AU5992400A (en) 2001-01-22
EP1196403A1 (fr) 2002-04-17
HK1043122A1 (zh) 2002-09-06
CA2376691C (en) 2009-09-01
CA2376691A1 (en) 2001-01-11
HRP20010949A2 (en) 2003-04-30
HU228983B1 (en) 2013-07-29
JP4931309B2 (ja) 2012-05-16
YU91101A (sh) 2004-09-03
AU778299B2 (en) 2004-11-25
BR0012463B1 (pt) 2014-11-04
WO2001002380A8 (fr) 2001-06-28
AR029374A1 (es) 2003-06-25
CN1156462C (zh) 2004-07-07
FR2795724B1 (fr) 2002-12-13
EA004048B1 (ru) 2003-12-25
DE60023898T2 (de) 2006-08-10
PL356186A1 (en) 2004-06-14
NO20016392L (no) 2002-03-04
HRP20010949B1 (en) 2006-06-30
TWI285640B (en) 2007-08-21
IL147069A (en) 2006-09-05
KR20020016877A (ko) 2002-03-06
BG106255A (en) 2002-10-31
KR100760446B1 (ko) 2007-10-04
HUP0202200A2 (en) 2002-10-28
WO2001002380A1 (fr) 2001-01-11
JP2003503487A (ja) 2003-01-28
EP1196403B1 (fr) 2005-11-09
MXPA01013207A (es) 2002-06-21
BG65209B1 (bg) 2007-07-31
UA71009C2 (uk) 2004-11-15
NO322230B1 (no) 2006-08-28
CO5021196A1 (es) 2001-03-27
CZ20014697A3 (cs) 2002-04-17
IL147069A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
DE60002992D1 (de) Dreiphasenabscheider
ID26447A (id) Turunan eritropoietin
EP1191957A4 (en) Ventricular assist device
DE10084676T1 (de) Einmallanzettvorrichtung
DE60004192D1 (de) Kompositverschlusskappe
DE60008638D1 (de) Förderbandabstreicher
DE60034061D1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
FI4433U1 (fi) Hiustenmuotoilusakset
DE60017027D1 (de) Gehrungseinrichtung
DE60045545D1 (de) Klebefolie
DE59909346D1 (de) Zylinderkopfdichtung
FI990089A0 (fi) Maalikoostumukset
DE60036617D1 (de) Monofluoralkylderivate
DE60013054D1 (de) Reissverschlusszuglasche
DE50008613D1 (de) Sicherungsring
ID30214A (id) Turunan resorsinol
DE60025623D1 (de) Bohrmeisselverbinder
DE60000107D1 (de) Formschliessvorrichtung
DE60034087D1 (de) Farbeditiersystem
DE50006899D1 (de) Antistatikum
DE60023130D1 (de) Scharnierarmbefestigung
DE50012482D1 (de) Tibiamarknagel
DK1196403T3 (da) Antipsykotiske N-aralkylaminer
DE60000940D1 (de) Wälzlagerstahl
DE60037169D1 (de) Chrominanzsignalinterpolation